Datavant

Company research

Public company, workplace, funding, and market signals

Updated Aug 5, 2026

Overview

Datavant is a healthcare data collaboration platform that securely connects identified and de-identified health data across payers, providers, life sciences, government, legal, insurance, and real-world-data organizations. It operates a large healthcare connectivity network and supports data linkage, retrieval, exchange, analytics, and real-world evidence workflows.

Primary product

Datavant’s data collaboration platform, including Datavant Connect, privacy-preserving tokenization/linkage, health-data retrieval, release-of-information, privacy solutions, and real-world-evidence analytics.

Founded

2014

Headquarters

New York, New York, United States

Team size

Approximately 2,000–2,500 employees; a third-party company profile reports 2,366 employees, but this figure is not independently confirmed by Datavant.

Work style

Flexible

Industry

Healthcare technology / software development

Sub-industry

Healthcare data interoperability, health information management, real-world data and real-world evidence

Offices

New York, New York, United States

Boston/Cambridge, Massachusetts, United States

San Diego, California, United States

Dallas, Texas, United States

Barcelona, Spain

Galway, Ireland

Tel Aviv, Israel

Business model

Enterprise SaaS and platform licensing

Usage- or workflow-based healthcare data services

Data connectivity, tokenization, linkage, and retrieval services

Real-world-data and real-world-evidence analytics

Release-of-information and health-information-management services

B2B partnerships with life-sciences, payer, provider, legal, and insurance organizations

Funding

Stage

Private, mature/growth-stage company; post-merger backed by private equity and strategic investors

Total raised

$80.5M

Latest round

Series B · Oct 2020

Incubator/Accelerator

Oct 2024 · Plug and Play Insurtech

Ciox Health merger / strategic investment

Jun 2021 · New Mountain Capital

$7B

Series B

Oct 2020 · Transformation Capital

Other / early venture round

Apr 2018 · Roivant Sciences

Series A

Apr 2018

People & investors

Leadership

Kyle Armbrester

Chief Executive Officer

Josh Builder

Chief Technology Officer

Arnaub Chatterjee

GM & President, Life Sciences

Sam Diederich

Chief Product Officer

Mark Harris

GM & President, Legal & Insurance

Stephen Mallinak

GM & President, Provider

Sachin Patel

GM & President, Payer

Kathryn Stalmack

Chief Legal Officer & General Counsel

Shannon West

Chief Strategy Officer

Jennifer Williams

Chief Financial Officer

Susan Yun

Chief People Officer

Ashley Greenberg

Chief of Staff

Annie Hurst

Head of Corporate Initiatives

Founders

Travis May

Founder / former President and Board member

Investors

Cigna Ventures

Flex Capital

Goldman Sachs Asset Management

Johnson & Johnson Innovation – JJDC

Labcorp

Merck Global Health Innovation Fund

New Mountain Capital

Pathfinder Venture Capital

Plug and Play Insurtech

Roivant Sciences

Sixth Street

Transformation Capital

Work & culture

Datavant describes a high-performing, fast-paced, technology-forward culture centered on trust, customer obsession, growth over comfort, teamwork, and solving complex healthcare problems. It emphasizes continuous learning and a mission to make health data secure, accessible, and actionable.

Work style

Flexible

Compensation

The company advertises competitive compensation and benefits; public sources reviewed did not provide a reliable standardized salary range or confirmed visa policy.

Benefits

Competitive benefits and rewards

Multiple health-plan options and coverage levels

Remote-friendly work environment with in-person collaboration

Generous parental and family leave

Professional development and continuous learning programs

Product & market

Pricing

Enterprise/custom pricing; public list pricing was not found. Offerings appear to be contracted platform, data, connectivity, retrieval, and analytics services.

Differentiators

—Large neutral healthcare data-connectivity network
—Privacy-preserving tokenization and linkage across identified and de-identified data
—Access spanning payers, providers, life sciences, government, legal, and insurance
—Combination of data retrieval, interoperability, linkage, and RWE analytics
—Datavant reports connectivity to 80,000+ hospitals and clinics, 100% of U.S. payers, and 350+ real-world-data partners
—Ability to link data without moving underlying information through Datavant Connect and AWS Clean Rooms

Technology

Privacy-preserving record linkage (PPRL)

Encrypted/tokenized patient identifiers

Datavant Connect

AWS Clean Rooms

Context-aware AI workflows

Clinical/EHR data integration

Real-world-evidence analytics

Data retrieval and abstraction

Cloud data infrastructure

Customers

Payers and health plans

Healthcare providers and health systems

Life-sciences and pharmaceutical companies

Government health agencies

Researchers

Legal organizations

Insurance organizations

Boehringer Ingelheim

Thermo Fisher Scientific / PPD

Indegene

Competitors

Health Catalyst

Komodo Health

Truveta

IQVIA

TriNetX

Clarivate

Ciox Health

Aetion

Scale & contact

Estimated revenue

Approximately $500 million–$1 billion annually; a third-party company profile estimates about $700 million, which is not a company-reported figure.

Signals & risks

Acquisition

Jun 2021

Datavant and Ciox Health announced a merger valued at $7.0 billion, creating the combined Datavant entity and substantially changing its scale, ownership, and operating structure.

Source

Acquisition

Sep 2024

Trace AI was reported as acquired by Datavant.

Source

Acquisition

Jun 2025

Ontellus was reported as acquired by Datavant.

Source

Acquisition

Jul 2025

Aetion was reported as acquired by Datavant.

Source

Acquisition

Sep 2025

ChartSwap Insights was reported as acquired by Datavant.

Source

Other

Jul 2026

Axios Pro reported that New Mountain Capital-backed Datavant was working with JPMorgan on a strategic review. This is a reported strategic process, not a confirmed sale or shutdown.

Source

Latest news

Scoop: NMC-backed Datavant working with JPM on strategic review

Axios Pro · Jul 2026

Axios Pro reported that Datavant was working with JPMorgan on a strategic review, potentially indicating a future ownership or exit process; no transaction was confirmed.

Lighten and Datavant Partner to Deliver Regulatory-Grade EHR Curation for Real-World Evidence Generation

Datavant newsroom · May 2026

The companies combined Lighten’s AI-native unstructured-EHR curation with Datavant’s RWE analytics platform for higher-fidelity longitudinal datasets.

Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant

Thermo Fisher Scientific / Datavant · Feb 2026

Thermo Fisher’s PPD business partnered with Datavant to connect de-identified research datasets and EMR data for recruitment, study design, and RWD generation.

Datavant and Indegene Partner to Power More Efficient Clinical Trial Recruitment

Datavant newsroom · Sep 2025

Datavant’s data-enrichment capabilities were embedded in Indegene’s recruitment platform to improve rare-disease and complex-trial prescreening and enrollment.

Jobs and careers at Datavant

157 jobs at Datavant

VP, Service Delivery

Remote

Service Delivery Salary

Remote - United States

Today

Remote

Full-time